How fast is the rate of weight loss on Wegovy?

How quickly does weight loss start with Wegovy?

Most people don't notice significant change in the first four weeks. The opening dose (0.25 mg) exists to let the body settle, not to drive weight loss. Nausea and other gastrointestinal effects are commonest at this stage, and keeping food down matters more than the scales. Once titration gets underway and doses climb toward the 1.7 mg and 2.4 mg range, appetite suppression becomes more pronounced and the rate of weight loss picks up.

In STEP 1, the steepest portion of the weight-loss curve tended to occur between roughly weeks 8 and 36, when participants were on or approaching the maintenance dose. After that, losses continued but at a slower pace as the body found a new set point. This pattern (quick relative to baseline, then tapering) is a normal biological response rather than a sign that treatment has stopped working. Our clinical team has a fuller guide to the Wegovy weight-loss timeline if you want week-by-week context.

One practical note: semaglutide reduces gastric emptying, which means you feel full faster and stay full longer. That effect on appetite is central to how semaglutide works and is the main driver of the calorie reduction that produces weight loss.

Does the 7.2 mg dose change the expected rate?

Yes, meaningfully. The MHRA approved the higher 7.2 mg Wegovy dose in January 2026, with a dedicated single-dose pen following in April 2026. Trials at this dose level reported approximately 20.7% average weight loss over 72 weeks, a notable step up from the 15% seen at 2.4 mg. For context, semaglutide's weight-loss profile has always been strong, but the higher dose narrows the gap with tirzepatide.

The titration path remains the same: you still begin at 0.25 mg and increase roughly every four weeks, with 7.2 mg as the new ceiling rather than an immediate option. That means the early months look similar to the standard pathway. The difference shows up in the later stages, once a higher maintenance dose is reached. Whether the 7.2 mg dose is right for you depends on how you've tolerated earlier steps, that's a conversation for your prescriber, not a decision to make from a results table.

If cost is a factor in your thinking, our Wegovy cost page sets out what private treatment involves in the UK and what an all-in price should cover.

What affects your personal rate of weight loss on Wegovy?

Trial averages are useful anchors, but they describe a population, not you. Several things shift where you land relative to that 15% figure. Starting BMI matters: people with a higher starting weight often see a larger absolute drop in kilograms, though the percentage loss may be similar. Reaching and tolerating the maintenance dose is probably the biggest single factor, participants who couldn't escalate to 2.4 mg lost less on average.

Diet and activity sit alongside the medicine rather than being optional extras. Wegovy's licence requires it to be used with a reduced-calorie diet and increased physical activity, and the STEP 1 trial included lifestyle counselling. The NHS England guidance on weight-management injections makes the same point: behavioural support amplifies what the medicine can do. Strength training, specifically, helps protect muscle mass during weight loss, which matters for long-term metabolic health.

Finally, individual biology plays a role that no one fully controls. Gut hormone responses vary between people, as do the genetic factors that influence appetite and fat storage. Some people are non-responders at a meaningful level, the NICE recommendation for semaglutide suggests reviewing whether to continue if less than 5% weight loss is achieved after six months on the maintenance dose. That review happens with your prescriber, not by self-adjusting. You can read more about the evidence base on our Wegovy and weight loss page.

When should you talk to a prescriber about your progress?

If weight loss has stalled well before six months, if side effects are making dose escalation difficult, or if you're unsure whether what you're experiencing is typical, those are exactly the conversations a prescriber is there for. Wegovy is a prescription-only medicine precisely because ongoing clinical judgement is part of what makes it safe and effective.

At nume, every repeat order is reviewed by a real prescriber before it's approved and dispatched, a named clinician reads your update, not an automated process. If you'd like to explore whether Wegovy or another licensed treatment suits your situation, speak to our prescribers through a free consultation. You can also learn more about the full Wegovy treatment or browse our weight-loss treatment options to see how the medicines compare. Our clinical team is available seven days a week for aftercare questions too.

One thing patients often mention: the pen itself, when it arrives in a plain DPD-tracked box, feels smaller and more discreet than they'd imagined. That's the reality of the weekly injection, a pre-filled device, not an elaborate ritual.